Reply to Donald L. Lamm and Nilay M. Gandhi's Letter to the editor re: Behfar Ehdaie, Richard Sylvester, Harry W. Herr. Maintenance bacillus calmette-guérin treatment of non-muscle-invasive bladder cancer: A critical evaluation of the evidence. Eur Urol 2013;64:579-85 Journal Article


Authors: Ehdaie, B.; Sylvester, R.; Herr, H. W.
Article Title: Reply to Donald L. Lamm and Nilay M. Gandhi's Letter to the editor re: Behfar Ehdaie, Richard Sylvester, Harry W. Herr. Maintenance bacillus calmette-guérin treatment of non-muscle-invasive bladder cancer: A critical evaluation of the evidence. Eur Urol 2013;64:579-85
Keywords: cancer survival; cancer surgery; cancer growth; cancer risk; drug safety; treatment duration; unspecified side effect; letter; bcg vaccine; cancer immunotherapy; maintenance therapy; cystoscopy; recurrence free survival; randomized controlled trial (topic); systemic disease; non muscle invasive bladder cancer; human; priority journal
Journal Title: European Urology
Volume: 65
Issue: 1
ISSN: 0302-2838
Publisher: Elsevier Science, Inc.  
Date Published: 2014-01-01
Start Page: e7
Language: English
DOI: 10.1016/j.eururo.2013.09.038
PROVIDER: scopus
PUBMED: 24113320
DOI/URL:
Notes: Export Date: 2 January 2014 -- CODEN: EUURA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Behfar Ehdaie
    173 Ehdaie
  2. Harry W Herr
    594 Herr